Psilocybin shows promise in slowing cellular aging and boosting longevity
A groundbreaking new study has revealed that psilocybin, the psychedelic compound found in magic mushrooms, may significantly delay aging by extending the cellular life span of human skin and lung cells by more than 50%. The findings offer exciting new possibilities for anti-aging therapies and healthy longevity.
Researchers from Baylor College of Medicine and Emory University conducted the study, recently published in the journal NPJ AGING. Led by Dr. Louise Hecker, the team explored psilocybin's systemic effects outside the brain, focusing on how it might impact the body's aging process at the cellular level.
"The overwhelming majority of what we know about psilocybin is from its impacts on the brain and mental health," said Dr. Hecker. "This study shows that it also has significant effects on cellular health, oxidative stress, and aging."
Psilocybin extends lifespan of human cells
Using cultured human lung and skin cells, researchers found that psilocin — the active metabolite of psilocybin — helped slow the cellular aging process. Cells exposed to psilocin maintained more youthful properties for a longer period and showed a more than 50% increase in lifespan compared to untreated cells.
You may like: Scientists unveil breakthrough that may slow and reverse heart aging
In mouse models, psilocybin-treated animals not only lived longer but exhibited healthier aging markers, including fewer white hairs and signs of hair regrowth. These results highlight psilocybin’s potential to protect the body from age-related diseases such as heart disease, neurodegeneration, and certain cancers.
Protecting telomeres and reducing oxidative stress
One of the key discoveries in the study was psilocybin's role in maintaining telomere length — the protective endcaps of chromosomes that shorten with age and are linked to cellular senescence.
"Psilocybin appears to reduce the ‘wear and tear’ of aging by improving DNA repair mechanisms, reducing oxidative stress, and preserving telomere length," Dr. Hecker explained. "These are all fundamental factors that contribute to healthy aging and disease prevention."
More research needed for clinical use
Despite the promising findings, experts caution that much more research is needed before psilocybin can be considered a safe and effective anti-aging therapy for humans.
Dr. Jack Jacoub, a board-certified medical oncologist, noted that while the results are intriguing, translating them into clinical settings will require rigorous human trials. "It’s too early to generalize these findings. Anti-aging is a vast umbrella, and any meaningful therapeutic applications must be studied extensively in specific human populations."
People also read: Worried your face is aging too fast? Here’s how to slow it down
He added that future studies could explore whether psilocybin helps accelerate tissue repair in conditions such as stroke or heart attack.
The road ahead
With over 150 clinical trials underway investigating psilocybin for mental health and neurological disorders, its potential now appears to extend even further into physical health and aging.
Stay informed. Stay ahead.
CLICK HERE TO FOLLOW Medical News Pakistan WhatsApp Channel for trusted healthcare updates, expert insights, clinical research, policy news, and medical breakthroughs—delivered directly to you.